These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17510451)

  • 1. Asymmetric dimethylarginine and hypertension in cerebral small vessel disease.
    Tsuda K
    Stroke; 2007 Jul; 38(7):e48; author reply e49. PubMed ID: 17510451
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia.
    Lücke T; Tsikas D; Kanzelmeyer N; Vaske B; Das AM
    Metabolism; 2006 Dec; 55(12):1599-603. PubMed ID: 17142130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine in cerebral small vessel disease.
    Khan U; Hassan A; Vallance P; Markus HS
    Stroke; 2007 Feb; 38(2):411-3. PubMed ID: 17204687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is asymmetric dimethylarginine a novel marker of atherosclerosis?
    Böger RH; Bode-Böger SM; Matsuoka H; Miyazaki H; Usui M; Ueda S; Okuda S; Imaizumi T; Cooke JP
    Circulation; 2000 Apr; 101(14):E160-1. PubMed ID: 10758065
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
    Abbasi F; Asagmi T; Cooke JP; Lamendola C; McLaughlin T; Reaven GM; Stuehlinger M; Tsao PS
    Am J Cardiol; 2001 Nov; 88(10):1201-3. PubMed ID: 11703973
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM
    J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine, an endogenous NO synthase inhibitor, in human breast milk.
    Tsukahara H; Nagasaka H
    Early Hum Dev; 2010 Feb; 86(2):69-70. PubMed ID: 20117887
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
    Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
    Zoccali C; Kielstein JT
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):314-20. PubMed ID: 16609301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation.
    Maeda T; Yoshimura T; Okamura H
    J Soc Gynecol Investig; 2003 Jan; 10(1):2-4. PubMed ID: 12517586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis].
    Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
    J Cardiol; 1999 Feb; 33(2):105-6. PubMed ID: 10087482
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine and cerebrovascular disorders in humans.
    Tsuda K
    Stroke; 2006 Dec; 37(12):2870; author reply 2871. PubMed ID: 17038655
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
    Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine and hypertension in carotid artery disease.
    Tsuda K
    Stroke; 2009 Dec; 40(12):e703; author reply e704. PubMed ID: 19875739
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography.
    Tsikas D; Junker W; Frölich JC
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):174-6. PubMed ID: 9498688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
    Zhang WR; Chen BM; Xiong Y; Tao LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):57-9. PubMed ID: 15871189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition.
    Zsuga J; Gesztelyi R; Török J; Kéki S; Bereczki D
    Med Hypotheses; 2005; 65(6):1091-8. PubMed ID: 16125868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.